Get Patent Opposition Report for Puren Pharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Puren Pharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3578173Dosage Form Containing Oxycodone And NaloxoneEURO CELTIQUEJul 26, 2023
EP3260117Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENMay 25, 2021
EP3342411Rapamycin Derivative For Treating Pancreas CancerNOVARTISApr 29, 2020